Pharmacological in vitro profiles of the enantiomers of BM5, a muscarinic partial agonist

被引：0
|
作者：
Sundquist, S
Nilvebrant, L
机构：
[1] Pharmacia & Upjohn Inc, Dept Pharmacol, SE-75182 Uppsala, Sweden
[2] Pharmacia & Upjohn Inc, Med Dept Urol, SE-75182 Uppsala, Sweden
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P530
引用
收藏
页码：R91 / R91
页数：1
相关论文
共 50 条
  • [1] Pharmacological characterisation of the enantiomers of BM-5, a muscarinic partial agonist with opposed enantioselectivity between affinity and efficacy
    Sundquist, S
    Modiri, AR
    Nilsson, BM
    Hacksell, U
    Gillberg, PG
    Nilvebrant, L
    PHARMACOLOGY & TOXICOLOGY, 2000, 86 (01): : 44 - 50
  • [2] BM-5, A CENTRALLY ACTIVE PARTIAL MUSCARINIC AGONIST WITH LOW TREMOROGENIC ACTIVITY - INVIVO AND INVITRO STUDIES
    ENGSTROM, C
    UNDEN, A
    LADINSKY, H
    CONSOLO, S
    BARTFAI, T
    PSYCHOPHARMACOLOGY, 1987, 91 (02) : 161 - 167
  • [3] SYNTHESIS AND BIOLOGICAL EVALUATION OF THE PARTIAL MUSCARINIC AGONIST FPL-14995 AND ITS ENANTIOMERS
    MACK, RA
    WU, ESC
    KOVER, A
    LOCH, JT
    MULLEN, G
    MURRAY, RJ
    BIALOBOK, P
    BLOSSER, JC
    GORDON, J
    HOWELL, A
    MACHULSKIS, A
    MCCREEDY, SA
    ORDY, JM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 173 - MEDI
  • [4] PHARMACOLOGICAL PROFILE OF THE DOPAMINE PARTIAL AGONIST, (+/--PD-128483 AND ITS ENANTIOMERS
    MELTZER, LT
    CAPRATHE, BW
    CHRISTOFFERSEN, CL
    CORBIN, AE
    JAEN, JC
    NINTEMAN, FW
    PUGSLEY, TA
    SERPA, KA
    SHIH, YH
    WHETZEL, SZ
    WILEY, JN
    WISE, LD
    HEFFNER, TG
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 266 (03): : 1177 - 1189
  • [5] The Roles of IL-18 in a Realistic Partial Body Irradiation with 5% Bone Marrow Sparing (PBI/BM5) Model
    Cui, Wanchang
    Hull, Lisa
    Zizzo, Alex
    Wang, Li
    Lin, Bin
    Zhai, Min
    Kumar, Vidya P.
    Xiao, Mang
    TOXICS, 2024, 12 (01)
  • [6] Comparison of the in vitro pharmacological profiles of long-acting muscarinic antagonists in human bronchus
    Naline, Emmanuel
    Delyle, Stanislas Grassin
    Salvator, Helene
    Brollo, Marion
    Faisy, Christophe
    Victoni, Tatiana
    Abrial, Charlotte
    Devillier, Philippe
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 49 : 46 - 53
  • [7] In vitro characterisation of the muscarinic receptor partial agonist, sabcomeline, in rat cortical and heart membranes
    Watson, JM
    Hunter, AJ
    Brown, AM
    Middlemiss, DN
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 370 (01) : 69 - 77
  • [8] In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT4 receptor
    Mikami, Tadayoshi
    Komada, Tohru
    Sugimoto, Hiromi
    Suzuki, Keiko
    Ohmi, Takashi
    Kimura, Naoji
    Naganeo, Rie
    Nakata, Eriko
    Nakatani, Keigo
    Toga, Tetsuo
    Eda, Hiroyuki
    Sakakibara, Minoru
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 609 (1-3) : 5 - 12
  • [9] BEHAVIORAL PHARMACOLOGICAL AND ELECTROENCEPHALOGRAPHIC EFFECTS OF THE 5-HT1A PARTIAL AGONIST IPSAPIRONE
    YAMAMOTO, T
    SHIBATA, S
    TESHIMA, K
    INOUE, Y
    USHIO, M
    TOMINAGA, K
    OHNO, M
    WATANABE, S
    UEKI, S
    FOLIA PHARMACOLOGICA JAPONICA, 1991, 98 (01) : 41 - 52
  • [10] Pharmacological Characterization of LY593093, an M1 Muscarinic Acetylcholine Receptor-Selective Partial Orthosteric Agonist
    Watt, Marla L.
    Schober, Douglas A.
    Hitchcock, Stephen
    Liu, Bin
    Chesterfield, Amy K.
    McKinzie, David
    Felder, Christian C.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (02): : 622 - 632
12345